Answers are grounded in this paper and cite their sources.
Given the available clinical evidence through the literature search when the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG2020) was creating, J-SSCG20201, 2 suggested administering vitamin C to septic patients based on the 11 available randomized control trials (RCT).3-13 Recently, Lamontagne et al.14 conducted a large multi-center RCT, including 872 septic patients, who required vasopressors, to evaluate the effect of high-dose vitamin C. This RCT revealed that the proportion of a composite of death or persistent organ dysfunction at 28 days in the vitamin C group was significantly higher than that in the placebo group. Additionally, several RCTs were published after our meta-analysis on this issue for J-SSCG2020. Therefore, we performed an updated systematic review on 20th June 2022. We identified 12 new RCTs14-25 and performed an updated meta-analysis using these 23 RCTs (Table 1 and Appendix S1). In our updated meta-analysis, the estimated value of the desirable anticipated effect was as follows: the length of ICU stay yielded a mean difference (MD) of 0.25 days shorter (95% Confidence interval (CI): 0.72 days shorter–0.22 days longer) (16 RCTs, n = 3,534). Thereby, the desirable anticipated effect was thought to be "trivial." The estimated values of the effects on mortality were as follows: long-term mortality, namely more than 60 days, yielded a risk difference (RD) of 42 more per 1,000 (95% CI: 8 more–83 more; 6 RCTs, n = 2,881), 28 or 30 days mortality yielded an RD of 34 fewer per 1,000 (95% CI: 70 fewer–12 more; 15 RCTs, n = 3,856), in-hospital mortality yielded an RD of 20 fewer per 1,000 (95% CI: 80 fewer–53 more; 12 RCTs, n = 2,344). Of these three mortalities, long-term mortality was chosen as the effect on mortality since we predetermined that the highest certainty of evidence was adopted. Subsequently, the estimated values of the other undesirable anticipated effects were as follows: the length of hospital stay yielded an MD of 0.24 days longer (95% CI: 0.97 days shorter–1.45 days longer; 12 RCTs, n = 3,407), and acute kidney injury yielded an RD of 6 more per 1,000 (95% CI: 20 fewer–38 more; 9 RCTs, n = 2,230). Thereby, the undesirable anticipated effects were "moderate." Thus, we presumed that administering vitamin C was inferior to the placebo or control. Judgment of values, acceptability, and feasibility were not changed, namely, "probably no important uncertainty or variability," "probably yes," and "probably yes," respectively. Accordingly, we revised our recommendation to "We suggest against administering vitamin C to septic patients (GRADE 2D: certainty of evidence = "very low")." Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Conflicts of Interest (COIs) and members' roles: All financial and non-financial competing interests were declared in the J-SSCG2020.1, 2 All data generated or analyzed during this study are included in this published article and its Appendix S1 files. All data generated or analyzed during this study are included in this published article and its Appendix S1 files. Appendix S1. PRISMA flow diagram, risk of bias summary, forrest plot, funnel plot, and evidence to decision table. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: